E-cadherin can limit the transforming properties of activating β-catenin mutations. - Wikidata - awgldk - TriplyDB

E-cadherin can limit the transforming properties of activating β-catenin mutations.

E-cadherin can limit the transforming properties of activating β-catenin mutations.

http://www.wikidata.org/entity/Q35736676

about

Mouse models of intestinal cancer Bidirectional KCNQ1:β-catenin interaction drives colorectal cancer cell differentiation Chemopreventive effect of chalcone derivative, L2H17, in colon cancer development.Structure-based mutational analysis of ICAT residues mediating negative regulation of β-catenin co-transcriptional activity Axitinib blocks Wnt/β-catenin signaling and directs asymmetric cell division in cancer Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression.SHISA6 Confers Resistance to Differentiation-Promoting Wnt/β-Catenin Signaling in Mouse Spermatogenic Stem Cells.The Wnt signaling pathway in cancer.CTNNB1-mutant colorectal carcinomas with immediate invasive growth: a model of interval cancers in Lynch syndrome.A Comparative Perspective on Wnt/β-Catenin Signalling in Cell Fate Determination.Epithelial-mesenchymal transition and nuclear β-catenin induced by conditional intestinal disruption of Cdh1 with Apc is E-cadherin EC1 domain dependent.The somatic mutation landscape of premalignant colorectal adenoma.Cancer: leaping the E-cadherin hurdle.Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer.Pharmacologic Manipulation of Wnt Signaling and Cancer Stem Cells.Germline mutations in hereditary diffuse gastric cancer.A growth factor-free culture system underscores the coordination between Wnt and BMP signaling in Lgr5 intestinal stem cell maintenance

P2860

Q26785563-B62A3AD1-550A-47BF-98BA-CD6D67889D73 Q33594870-CC1DE771-E2B2-43E5-9AAF-B3AE6F5A9B16 Q35836432-D56BA079-2223-4B90-976C-9ED8B7692350 Q36300744-A8C6EF7B-BF50-4D5F-A296-A5E3CD591282 Q37200030-53320416-1B4E-4A02-8F37-04F61C7CCF2F Q37697139-07D6046D-DB4E-44CA-8D44-211A70C08011 Q37707413-0059A982-9804-4C8F-88EF-91CE2A44BAD6 Q38699352-1913225F-0DFC-4478-BE76-74BA1EFE456C Q38897378-EB395B20-0908-4080-946D-E51055CA095D Q39242337-076393E5-9280-4049-A4C9-175B403DCBEB Q39448813-1A8F4272-8742-48A9-8B34-234F25029B8E Q40162596-6EABB5B6-F561-45DB-B3CC-D3885DAD50BF Q43249499-7EADD081-2A06-4CD2-AA58-DEF36328BA06 Q45071326-9449E404-7D4F-4423-BBB7-6EEA59798B7D Q46164259-E7059EF5-EAF5-43FE-82FD-E9EF33212676 Q53177108-E54D99BB-5C91-4C42-B27E-52E97E8C8929 Q58765804-5731704A-31B7-4640-8954-9F71BC1252F6

P2860

E-cadherin can limit the transforming properties of activating β-catenin mutations.

http://www.wikidata.org/entity/Q35736676

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

E-cadherin can limit the transforming properties of activating β-catenin mutations.

@ast

E-cadherin can limit the transforming properties of activating β-catenin mutations.

@en

type

label

E-cadherin can limit the transforming properties of activating β-catenin mutations.

@ast

E-cadherin can limit the transforming properties of activating β-catenin mutations.

@en

prefLabel

E-cadherin can limit the transforming properties of activating β-catenin mutations.

@ast

E-cadherin can limit the transforming properties of activating β-catenin mutations.

@en

P1433

Q35736676-67220637-7AE6-4232-AD6F-57AEB929F978

P1476

Q35736676-4EFDA85B-C4AC-40C5-BED1-D7DB389C2CAF

P2093

Q35736676-00E40A9E-AB39-4490-8445-71002373DDD4

Q35736676-0BAB60AD-7B1D-4DC2-8ECD-8126D5CB5ED5

Q35736676-35FD5245-783B-4A02-A637-C37F97200EB9

Q35736676-4B2F9E69-F6A0-433D-AA0A-807973010EB8

Q35736676-4F32BEE8-AEFC-42B1-8539-72F5B52A79E1

Q35736676-567F282D-B714-4FD8-9CA5-0F90D7FF7371

Q35736676-62FE25D1-D49C-45BB-A6CB-A1409DC86362

Q35736676-8627DBB4-5C2A-4A04-8EFA-F8B15B4D8C55

Q35736676-AEA8D0C6-3C34-4CC5-8FB9-FD7BCB469919

Q35736676-AF83F868-09AB-4E5D-AF12-18513930FBB9

P2860

Q35736676-03FFBE0D-81F5-4C55-A61E-45F060683DC8

Q35736676-0F1C9A5A-AA5D-45FD-AAD1-5CD395D93175

Q35736676-3327F8D6-4EE6-42CE-81DD-FDCAADB0DDF0

Q35736676-338ACEE6-66FD-4CF1-A7D5-182AD4A9D8A3

Q35736676-3A4CDE58-3549-40BA-A315-4EFB3CFEB8A8

Q35736676-4324D226-9B01-4DAD-A64D-FE45644CB04E

Q35736676-470A4DDC-2C10-47CE-A6D0-1157880B815B

Q35736676-4A3FC66F-CC10-4654-A4C6-38D5BBC6AB45

Q35736676-4A6A9AC8-C2A7-4B37-8F6E-2846B7015532

Q35736676-4B0E4A00-B8E3-4A1A-BBC1-8DFAA23690E5

P304

Q35736676-3BC09750-4ACF-40B8-82B9-9C618279E20A

P31

Q35736676-D2FA2988-E66A-4FEE-9E3E-D6E38D1C5E20

P356

Q35736676-9E066C9C-7429-41CF-954C-800EC8B7F57A

P407

Q35736676-98B44BF8-D74B-46A4-B135-4A185034F5D4

P433

Q35736676-871CC95D-9A54-4172-9085-35AB65724764

P478

Q35736676-40D58568-EC52-4CF6-8E6B-A4E91A893DE0

P50

Q35736676-4CCE56DB-821B-4792-BECB-2584962D7441

Q35736676-881C501B-98CD-4160-9D98-2CF0C06939B6

Q35736676-A40489A9-7AE0-4487-8752-83DD8F3A91E2

Q35736676-AB3884E8-CE89-415A-BBF5-F67876DDC4DD

Q35736676-B017DA5B-3889-4328-BB85-99B293ACFAD4

Q35736676-B45D26BB-8011-4374-8E6F-6B8DA97B742E

Q35736676-DF639DC6-958D-4A20-A8CA-63EDCEBEE49F

Q35736676-E4A348C7-CC1E-46F0-9A40-E5CD0B2CE7CC

P577

Q35736676-FEE5A6E2-9DAA-485B-B89E-C5D3A9948B8A

P5875

Q35736676-39341B8B-7D8D-4D77-8768-B3C858D55F6E

P698

Q35736676-CFD2BF55-F627-4946-BE0B-96AF411742C5

P932

Q35736676-F36FAF49-5EA6-49A3-8034-EDA115DE2498

P356

P1433

The EMBO Journal

P1476

E-cadherin can limit the transforming properties of activating β-catenin mutations.

@en

P2093

Alastair Watson

http://www.w3.org/2001/XMLSchema#string

Andrew D Campbell

http://www.w3.org/2001/XMLSchema#string

Ann Hedley

http://www.w3.org/2001/XMLSchema#string

Aoife Maguire

http://www.w3.org/2001/XMLSchema#string

Brendan Doyle

http://www.w3.org/2001/XMLSchema#string

Fatih Ceteci

http://www.w3.org/2001/XMLSchema#string

Fei Song

http://www.w3.org/2001/XMLSchema#string

Gabriela Kalna

http://www.w3.org/2001/XMLSchema#string

Guenievre Moreaux

http://www.w3.org/2001/XMLSchema#string

James Matthews

http://www.w3.org/2001/XMLSchema#string

P2860

Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene

Comprehensive molecular characterization of human colon and rectal cancer

Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions

Wnt/beta-catenin signaling in development and disease

Identification of stem cells in small intestine and colon by marker gene Lgr5

Lessons from hereditary colorectal cancer

Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

Crypt stem cells as the cells-of-origin of intestinal cancer

P304

2321-2333

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.15252/EMBJ.201591739

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280693298

http://www.w3.org/2001/XMLSchema#string

P698

26240067

http://www.w3.org/2001/XMLSchema#string

P932

4570519

http://www.w3.org/2001/XMLSchema#string